Very low rate of humoral response after a third COVID-19 vaccine dose in patients with autoimmune diseases treated with rituximab and non-responders to two doses

Por Samuel Bitoun, Xavier Mariette, Jerome Avouac, Raphaele Seror, Gaetane Nocturne, Flore Rozenberg, Julien Henry, Rakiba Belkhir, Omar Al Tabaa, Roba Ghossan, Alice Andrée Mariaggi, Christelle Vauloup-Fellous
Publicado em 2022-05-01